University of California, Los Angeles

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1919-05-23

Employees: 10K

Market Cap: -

Website: http://www.ucla.edu

Clinical Trials

Physiologic Monitoring of Antidepressant Treatment Response

Phase 4

Completed

Conditions: Depression

Interventions: Drug: venlafaxine (Effexor)

First Posted Date: 2008-09-25

Last Posted Date: 2014-07-03

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 37

Registration Number: NCT00759317

Locations: 🇺🇸
UCLA Laboratory of Brain, Behavior, and Pharmacology, Los Angeles, California, United States

Electroencephalography (EEG) Biomarkers of Response in Depression

Phase 4

Completed

Conditions: Major Depressive Disorder

Interventions: Drug: venlafaxine (Effexor)
Drug: placebo

First Posted Date: 2008-09-25

Last Posted Date: 2008-09-25

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 44

Registration Number: NCT00759122

Locations: 🇺🇸
UCLA Laboratory of Brain, Behavior, and Pharmacology, Los Angeles, California, United States

Curcumin in Rheumatoid Arthritis

Early Phase 1

Completed

Conditions: Rheumatoid Arthritis

First Posted Date: 2008-09-15

Last Posted Date: 2023-09-29

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 40

Registration Number: NCT00752154

Locations: 🇺🇸
Swamy Venuturpualli, M.D., 8737 Beverly Blvd., #203, Beverly Hills, California, United States
🇺🇸
UCLA, 1000 Veteran Avenue, Rehab Building, 3rd Floor, Los Angeles, California, United States

Cognitive Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder

Not Applicable

Completed

Conditions: Obsessive-Compulsive Disorder

Interventions: Behavioral: Cognitive Behavioral Therapy (CBT)
Behavioral: Waitlist

First Posted Date: 2008-09-09

Last Posted Date: 2020-03-25

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 119

Registration Number: NCT00748761

Locations: 🇺🇸
UCLA Child Psychiatry, Los Angeles, California, United States

Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV Therapy

Completed

Conditions: HIV
Hepatitis C
Infections

Interventions: Drug: Pegylated interferon alfa and ribavirin (PEG-IFN/RBV)

First Posted Date: 2008-09-05

Last Posted Date: 2016-05-13

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 330

Registration Number: NCT00747539

Locations: 🇺🇸
Kaiser Permanente Infectious Diseases, Antelope Valley, Lancaster, California, United States
🇺🇸
University of California, Los Angeles, School of Medicine, Los Angeles, California, United States
🇺🇸
Veterans Administration Greater Los Angeles Healthcare System, Los Angeles, California, United States

and more 1 locations

Four Models of Telephone Support for Stimulant Recovery

Not Applicable

Completed

Conditions: Drug Addiction

Interventions: Behavioral: Continuing Care Telephone Support

First Posted Date: 2008-08-29

Last Posted Date: 2016-11-28

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 302

Registration Number: NCT00744068

Locations: 🇺🇸
UCLA Integrated Substance Abuse Programs, Los Angeles, California, United States
🇺🇸
Matrix Institute on Addicitions, Woodland Hills, California, United States
🇺🇸
Twin Town Treatment Center, West Hollywood, California, United States

and more 1 locations

Web-Based Survey of Pain, Stress and Complementary and Alternative Medicine

Completed

Conditions: Gastrointestinal Diseases
Chronic Pain
Stress
Anxiety
Depression

First Posted Date: 2008-08-22

Last Posted Date: 2014-03-27

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 2300

Registration Number: NCT00740233

Randomized Crossover Study of Magnesium Supplementation

Not Applicable

Completed

Conditions: Diabetes Mellitus, Type 2
Inflammation

Interventions: Other: Placebo

First Posted Date: 2008-08-20

Last Posted Date: 2012-06-19

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 14

Registration Number: NCT00737815

Locations: 🇺🇸
UCLA General Clinical Research Center, Los Angeles, California, United States

An Assessment of the Safety of Varenicline in Methamphetamine-dependent Volunteers

Phase 1

Completed

Conditions: Methamphetamine Addiction
Amphetamine Addiction
Crystal Meth Addiction

Interventions: Drug: Varenicline, then placebo
Drug: Placebo, then varenicline

First Posted Date: 2008-07-11

Last Posted Date: 2018-03-13

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 8

Registration Number: NCT00713479

Locations: 🇺🇸
UCLA NPI, Los Angeles, California, United States

Modafinil Effects on Cognition in Schizophrenia Patients

Phase 4

Completed

Conditions: Schizophrenia

Interventions: Drug: modafinil (M1, M2, M4)

First Posted Date: 2008-07-08

Last Posted Date: 2017-09-29

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 29

Registration Number: NCT00711464

Locations: 🇺🇸
University of California, Davis School of Medicine, Sacramento, California, United States
🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy